EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Explainable AI-Driven Identification of Multimodal Biomarkers for Early Prediction of Cognitive Decline

A. H. M. Fahad, Masahiko Nakatsui, Takeshi Abe, Takahide Hayano, M. H. Mahbub, Ryosuke Hase, Natsu Yamaguchi, Yoshihiro Hayakawa, Yusuke Inohana, Yutaka Umakoshi, Ryo Yamaguchi, Ren Kimura und 11 weitere

AI in Medicine · 2026

DOI: 10.3390/aimed1020012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AI in Medicine, 2026. Verfasst von A. H. M. Fahad und 22 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shimadzu Corporation, Kao Corporation, Kyodo Milk Industry Co., Ltd..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study developed a two-stage, explainable machine learning framework to predict 18-month MMSE-based cognitive status from baseline multimodal data in community-dwelling older adults in Japan. A hierarchical design was used in which Stage 1 distinguished cognitively Normal participants from those with any abnormality (Possible Mild Cognitive Impairment (MCI) or Impaired), and Stage 2 further separated Possible MCI from Impaired within the abnormal subgroup. Both an Imbalanced-Learn Random Forest and a penalized logistic regression baseline were trained under Leave-One-Out Cross-Validation, yielding fair discrimination in Stage 1 (Random Forest AUC = 0.72, accuracy = 0.71; logistic regression AUC = 0.71, accuracy = 0.76) and apparently strong separability in Stage 2 (Random Forest AUC = 0.95, accuracy = 0.96; logistic regression AUC = 0.82, accuracy = 0.92) in a small sample size with high class imbalance. SHapley Additive exPlanations (SHAP) with TreeExplainer for Random Forest and LinearExplainer for logistic regression were used to identify interpretable biomarkers at each stage though feature attribution. In Stage 1, both models highlighted renal and systemic metabolic markers (e.g., creatinine, uric acid, blood urea nitrogen), amino acid and redox-related metabolites (including D-serine, D-amino acid proportions, L-asparagine, alanine, L-glutamic acid, cysteine, methionine sulfoxide), and wearable-derived activity variability (e.g., fluctuation coefficients and steps per minute), with the Simpson index of gut microbiome diversity also contributing in the logistic model. In Stage 2, the models converged on a distinct signature involving glucose and albumin, uric acid and uridine, choline and carnitine, multiple amino acids (such as phenylalanine, proline, ornithine, tryptophan, threonine, and short-chain amino acids), oxidative/energy markers (niacinamide, methionine, methionine sulfoxide, ergothioneine), hematologic indices, and high-MET activity fluctuation metrics. Collectively, these results support a stage-dependent, multisystem view of cognitive aging in which broad renal–metabolic, amino acid, and behavioral vulnerabilities characterize early abnormality, whereas more pronounced alterations in energy metabolism, nucleotide and choline pathways, oxidative stress, and activity irregularity accompany progression from Possible MCI to Impaired status. By combining routine clinical chemistry, targeted metabolomics, gut microbiome diversity, and wearable-derived behavioral measures within an explainable AI framework, this two-stage approach illustrates a scalable, biologically grounded strategy for stage-aware risk stratification and monitoring of cognitive decline in community settings.

Förderung

  • Shimadzu Corporation
  • Kao Corporation
  • Kyodo Milk Industry Co., Ltd.

Zitieren

APA

Fahad, A. H. M., Nakatsui, M., Abe, T., Hayano, T., Mahbub, M. H., Hase, R., Yamaguchi, N., Hayakawa, Y., Inohana, Y., Umakoshi, Y., Yamaguchi, R., Kimura, R., Tsujimura, H., Matsumoto, M., Higashijima, F., Yoshimoto, T., Kimura, K., Hirano, T., Ohishi, K., …, & Asai, Y. (2026). Explainable AI-Driven Identification of Multimodal Biomarkers for Early Prediction of Cognitive Decline. AI in Medicine. https://doi.org/10.3390/aimed1020012

Vancouver

Fahad AHM, Nakatsui M, Abe T, Hayano T, Mahbub MH, Hase R, et al. Explainable AI-Driven Identification of Multimodal Biomarkers for Early Prediction of Cognitive Decline. AI in Medicine. 2026. doi:10.3390/aimed1020012

BibTeX
@article{Fahad2026,
  author = {Fahad, A. H. M. and Nakatsui, Masahiko and Abe, Takeshi and Hayano, Takahide and Mahbub, M. H. and Hase, Ryosuke and Yamaguchi, Natsu and Hayakawa, Yoshihiro and Inohana, Yusuke and Umakoshi, Yutaka and Yamaguchi, Ryo and Kimura, Ren and Tsujimura, Hisashi and Matsumoto, Mitsuharu and Higashijima, Fumiaki and Yoshimoto, Takuya and Kimura, Kazuhiro and Hirano, Tsunahiko and Ohishi, Keiji and Doi, Keiko and Matsunaga, Kazuto and Tanabe, Tsuyoshi and Asai, Yoshiyuki},
  title = {Explainable AI-Driven Identification of Multimodal Biomarkers for Early Prediction of Cognitive Decline},
  journal = {AI in Medicine},
  year = {2026},
  doi = {10.3390/aimed1020012}
}
Kostenlos starten →